(Credit-Canva)
The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.
Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.
Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.
Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.
Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.
Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.
Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.
According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.
All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.
Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.
Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.
Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.
People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.
Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.
Credit: Canva/Instagram
A young Internal Medicine doctor from Chandigarh has highlighted shocking malpractices followed by a well-known private hospital.
In a widely shared video posted on social media platform Instagram, Dr Prabhleen Kaur alleged that all patients arriving at the hospital in the city are being forcibly kept in Intensive Care Units (ICUs) even when it is not required.
The doctor had joined the hospital, as it was paying well and was near her clinic. However, seeing the blatant scam, she resigned in just one day.
Also Read: Scientists Link Vaping to 2 Types of Cancer; DNA-Damaging Chemicals to Blame
“I joined a very reputed hospital. I thought I would work there in the mornings and run OPD at my own clinic in the evenings. They were paying really well, no doubt about that,” the doctor said in the video.
The doctor alleged that the hospital “just needed a physician for the show”, while the entire handling of patients was being done by the owner, a gynecologist.
“But on my very first day, I realised that they only needed a physician in name. The hospital owner, who was a gynaecologist and not a physician, was managing all the patients herself. That means she would decide every patient should be admitted, and she would also decide that every admitted patient should be kept in the ICU – and kept there for as many days as possible,” Kaur said.
She further claimed that the goal at the said hospital was to make the patients remain admitted in the ICU for as long as possible. Kaur added she was deeply disturbed seeing this and refused to be part of a system that “harms patients for money.”
“It would have been my name, but their wrongdoing. So I resigned, because I cannot allow someone to use me as a front for unethical practices,” she said.
The doctor did not mention the name of the hospital. And HealthandMe could not independently verify the details and the authenticity of the post.
However, the incident reignites concerns over accountability, patient safety, and standards of care in the country.
The video went viral and the netizens found it concerning, and some also pointed out that such issues are common with many hospitals across the country.
"Unfortunately, most doctors are doing this unethical practice these days,” a user said.
“No surprise— the moment you enter a hospital, the first question is about insurance coverage. Feels like treatment comes second and billing comes first,” added another.
Some also lauded the doctor for resigning and sounding the alarm.
“Salute to your integrity. Rest of the Indians are just after making money,” said a user, while another noted: “Respect to this doctor for choosing her conscience over money".
Also read: NASA’s Artemis II Mission To Test Human Health in Deep Space
This is not the first such incident of hospital malpractice in the country.
Days earlier, a doctor from Assam called out private hospitals for overcharging patients with inflated medicine prices and unnecessary lab tests.
Dr Priyam Bordoloi said that corporate hospital chains rely on “predatory” practices and become a “financial sinkhole” for patients.
Earlier in January this year, a viral video with allegations of gross medical negligence and institutional apathy at Dhubri Medical College and Hospital (DMCH) sparked public outrage.
The video showed a family accusing hospital staff of failing to provide basic care, delaying critical dialysis treatment, and obstructing an emergency transfer.
The incident involved a 74-year-old Fulchand Chowdhury, whose condition reportedly worsened due to lapses in ICU monitoring, sanitation, and patient safety.
The family claimed they were forced to care for him themselves and faced resistance when seeking transfer to a private facility.
Also read: Bob Harris: BBC Radio 2 Host Hospitalized For Prostate Cancer Treatment
In January 2024, India launched guidelines for hospitals on ICU admissions and directed that hospitals cannot admit critically ill patients to the ICU without the consent of the patient and family.
According to the latest guidelines, patients who are critically ill should not be admitted to an ICU if they do not give their consent.
"Critically ill patients should not be admitted to the ICU; if the patient or next-of-kin informed refusal to be admitted in ICU."
Credit: NASA
Nearly 60 years after humanity first set foot on the Moon, NASA has launched its historic Artemis II mission, marking the first crewed journey around the lunar surface.
The nearly 10-day flight was launched successfully on April 1 from the Kennedy Space Center (KSC) in Florida at 6:24 p.m. EDT.
Four astronauts were launched to the surface of the Moon aboard Orion, which lifted off atop NASA's Space Launch System.
The Orion spacecraft flight carries NASA astronauts Reid Wiseman, Victor Glover, and Christina Koch, along with Canadian Space Agency astronaut Jeremy Hansen.
The crew aims to loop around the moon and return to Earth on a free-return trajectory, reaching roughly 4,700 miles (7,560 kilometers) beyond the moon's far side — farther than Apollo 8's historic lunar flyby and the most distant journey ever attempted by humans.
During the 10-day journey, the four astronauts will also perform several science experiments, along with scientists on Earth, to facilitate science investigations to inform future human spaceflight missions.
NASA stated that the Artemis II science operations will lay the foundation for safe and efficient human exploration of the Moon and Mars.
The study will evaluate how crew members perform individually and as a team throughout the mission, including how easily they can move around within the confined space of their Orion spacecraft.
Scientists will analyze blood and saliva samples from Artemis II crew members to see how deep space changes the immune system.
Crews are supplying a consistent set of health information to a data bank so that future researchers can learn more about astronaut health.
Equipment will monitor radiation levels inside and outside the Orion capsule to help characterize the deep space environment.

“The findings are expected to provide vital insights for future missions to destinations beyond low Earth orbit, including Mars,” said Laurie Abadie, an aerospace engineer for the program at NASA’s Johnson Space Center in Houston.
“The lessons we learn from this crew will help us to more safely accomplish deep space missions and research,” she said.
Steven Platts, chief scientist for human research at NASA Johnson, explained the mission will need to protect against challenges, including exposure to higher radiation levels than on the International Space Station, since the crew will be farther from Earth.
“Together, these studies will allow scientists to better understand how the immune system performs in deep space, teach us more about astronauts’ overall well-being ahead of a Mars mission, and help scientists develop ways to ensure the health and success of crew members,” he said.
Credit: Canva
The emerging COVID-19 BA.3.2 variant, dubbed Cicada and detected in 23 countries, may not pose a significant global threat, claimed a study.
The 2025 study, published in the mBio journal, showed that the immune response of the BA 3.2 COVID variant from vaccines or prior infection is less effective than against the original strain. The antibody effectiveness is three times lower against the BA.3.2 variant. However, it does not mean that there is no protection at all.
“BA.3.2 showed intermediate neutralization, representing a 3-fold reduction compared to the ancestral strain,” said the researchers from the Icahn School of Medicine at Mount Sinai, US.
“BA.3.2 occupied an intermediate but distinctly separate position,” they said, adding that the variant “shows substantial immune escape potential that threatens protection”.
In the study, the researchers used antigenic mapping to assess neutralizing antibody responses in 56 adults with varied exposure histories following KP.2 vaccination against emerging variants, including LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2.
While KP.2 vaccination enhanced neutralization against homologous variants, substantial reductions in neutralizing activity were observed against emerging Omicron variants across all exposure groups.
Exposure history showed some influence on neutralization breadth, with self-reported vaccination-only participants exhibiting better cross-neutralization compared to individuals with hybrid immunity.
The findings highlight the ongoing challenge of maintaining vaccine effectiveness against evolving SARS-CoV-2 variants and argue for continuous updating of vaccines, the researchers said.
“Despite its extraordinary number of mutations, BA.3.2 is not able to overcome immunity from vaccination, finds study. Other variants were more capable of evading immunity. This indicates it is not a major real-world threat,” said Dr Rajeev Jayadevan, Ex-President of IMA Cochin and Convener of the Research Cell, Kerala, in a post on social media platform X. He was not part of the study.
BA.3.2 is a descendant of the Omicron BA.3 lineage. It is genetically distinct from the previously circulating JN.1 lineages (including LP.8.1 and XFG).
BA.3.2 comprises two major branches, BA.3.2.1 and BA.3.2.2. BA.3.2.2 also has substitutions like: K356T, A575S, R681H, and R1162P, the CDC report said.
What makes the BA.3.2 variant special is the “70 to 75 substitutions and deletions in the gene sequence of its spike protein”, according to the US CDC’s latest Morbidity and Mortality Weekly Report.
“BA.3.2 represents a new lineage of SARS-CoV-2, genetically distinct from the JN.1 lineages (including LP.8.1 and XFG) that have circulated in the US since January 2024,” said the CDC researchers.
“BA.3.2 mutations in the spike protein have the potential to reduce protection from a previous infection or vaccination,” they added.
However, the new Cicada variant with around 75 genetic changes in its spike protein is likely to disproportionately affect children, as per an expert, who noted its presence in the UK.
“Some people have done analysis on this, suggesting it may be more prevalent among young children. Children get infections all the time, but this might be something to do with the fact that they have never been exposed to Covid vaccines," Prof Ravindra Gupta, of Cambridge University, who advised the UK government during the pandemic, was quoted as saying to The Mirror.
“So this is something we’re looking at in the lab to try and work out why. The problem with this is that it is an infection that spreads fast. Eventually, it ends up in someone vulnerable," he added.
Symptoms seem to be similar to those of other recent variants and include
sore throat,
cough,
congestion,
fatigue,
headache
fever.
According to the CDC, the Cicada variant is also likely to raise gastrointestinal issues such as nausea or diarrhea.
© 2024 Bennett, Coleman & Company Limited